BOI:EPA
Boiron USA
€ १९.५०
०.००%
(०.००) 1D
नोभेम्बर ५, १७:३५:१७ GMT+१ · EUR
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for BOI...
Mkt. cap
३४.७० करोड
Avg. vol.
४.९५ हजार
Volume
०.००
P/E ratio
१२.९३
52-wk high
€ ३२.२५
52-wk low
€ १६.९०
EPS
€ १.५१
Shares outstanding
१.७५ करोड
No. of employees
३ हजार
Mkt. cap
३४.७० करोड
Avg. vol.
४.९५ हजार
Volume
०.००
P/E ratio
१२.९३
52-wk high
€ ३२.२५
52-wk low
€ १६.९०
EPS
€ १.५१
Shares outstanding
१.७५ करोड
No. of employees
३ हजार
News stories
From web sources and news partners
Investing.com
·
४३ मिनेट पहिले
Nasdaq Volatility Shock Warns Against Buying Too Early
Yahoo Finance
·
१ घण्टा पहिले
Nasdaq Stock Market Correction: 3 Words From Warren Buffett To Remember RIght Now
Bloomberg.com
·
१ घण्टा पहिले
Asian Stocks Brace for Selloff as AI Rout Deepens: Markets Wrap
MarketWatch
·
८ घण्टा पहिले
Tech stocks log worst day since 2020 as carnage comes to the AI trade
Profile
Boiron is a manufacturer of homeopathic products, headquartered in France and with an operating presence in 59 countries worldwide. It is the largest manufacturer of homeopathic products in the world. In 2004, it had a workforce of 2,779 and turnover of € 313 million. It is a member of the CAC Small stock index.
In June 2005, the firm acquired Dolisos Laboratories, then the world's second largest manufacturer of homeopathic preparations.
Products of Boiron include mono- and poly-preparations, which Boiron refer to as "proprietary drugs".
Homeopathy is a pseudoscience with no evidence of effectiveness for stated claims or plausible mechanism of medicinal effect, and several class action lawsuits have been filed on behalf of consumers claiming that Boiron's homeopathic products, including Children's Coldcalm and Oscillococcinum, are useless and Boiron's marketing of these products is deceptive. Wikipedia
About Boiron USA